XCL1



XCL1

V1VV1G2GG2T3TT3E4EE4V5VV5L6LL6Q7QQ7E8EE8S9SS9I10II10C11CC11V12VV12S13SS13L14LL14R15RR15T16TT16Q17QQ17R18RR18L19LL19P20PP20V21VV21Q22QQ22K23KK23I24II24K25KK25T26TT26Y27YY27T28TT28I29II29K30KK30E31EE31G32GG32A33AA33M34MM34R35RR35A36AA36V37VV37I38II38F39FF39V40VV40T41TT41K42KK42R43RR43G44GG44L45LL45R46RR46I47II47... and 46 more residue(s)...... and 46 more residue(s)

SMILES None
InChIKey None
Sequence VGTEVLQESICVSLRTQRLPVQKIKTYTIKEGAMRAVIFVTKRGLRICADPQAKWVKTAIKTVDGRASASKSKAETIPTQAQRSASTAVTLTG

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

XCL1

V1VV1G2GG2T3TT3E4EE4V5VV5L6LL6Q7QQ7E8EE8S9SS9I10II10C11CC11V12VV12S13SS13L14LL14R15RR15T16TT16Q17QQ17R18RR18L19LL19P20PP20V21VV21Q22QQ22K23KK23I24II24K25KK25T26TT26Y27YY27T28TT28I29II29K30KK30E31EE31G32GG32A33AA33M34MM34R35RR35A36AA36V37VV37I38II38F39FF39V40VV40T41TT41K42KK42R43RR43G44GG44L45LL45R46RR46I47II47... and 46 more residue(s)...... and 46 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.